Abstract: Scaffolds are physical substrates for cell attachment, proliferation, and differentiation, ultimately leading to the regeneration of tissues. They must be designed according to specific biomechanical requirements such as mechanical properties, surface characteristics, biodegradability, biocompatibility, and porosity. The optimal design of a scaffold for a specific tissue strongly depends on both materials and manufacturing processes. Polymeric scaffolds reinforced with electro-active particles could play a key role in tissue engineering by modulating cell proliferation and differentiation. This paper investigates the use of an extrusion additive manufacturing system to produce PCL/pristine graphene scaffolds for bone tissue applications. PCL/pristine graphene blends were prepared using a melt blending process. Scaffolds with regular and reproducible architecture were produced with different concentrations of pristine graphene. Scaffolds were evaluated from morphological, mechanical, and biological view. The results suggest that the addition of pristine graphene improves the mechanical performance of the scaffolds, reduces the hydrophobicity, and improves cell viability and proliferation.
Introduction
one is a highly anisotropic tissue, able to heal and remodel without leaving any scar in cases of very limited damage or fracture. However, in pathological fractures, traumatic bone loss or primary tumour resection, where the bone defect exceeds a critical size, bone is no longer able to heal itself [1, 2] . Additionally, this regenerative ability reduces with age [3] . With the increasing life expectancy of the population, osteoporotic fractures will have a serious economic impact on society and patient's quality of B life. It is estimated that in Europe 179,000 men and 611,000 women will suffer hip fracture each year and the cost of all osteoporotic fractures in the EU will increase from the current 31.7 billion euros to 76.7 billion euros by 2050 [4] . In these cases, the clinical approach is the use of bone grafts, defined as an implanted material that promotes bone healing alone or in combination with other materials, through osteogenesis, osteoinduction, and osteoconduction [5] . Bone grafts can be divided into autografts, allografts, and xenografts [1, 2, 6] . However, there are many inherent limitations with this procedure. Autografts are considered to be the most effective approach, however, they present some drawbacks such as site morbidity, pain, and prolonged hospitalisation [2, 3] . Allografts are associated with rejection problems, transmission of diseases and infections from donor to recipient, and cost [1, 2, 6] . Xenografts major limitations are related to their lack of osteogenic properties, risk of immunogenicity and transmission of infections and zoonotic diseases, and poor clinical outcome [5, 6] . Therefore, biofabrication-the combined use of additive manufacturing techniques, biocompatible and biodegradable materials, cells, growth factors, etc., for the fabrication of bioactive scaffolds (synthetic grafts)-is becoming a promising alternative for grafting [7] [8] [9] [10] [11] [12] [13] [14] . In this approach, scaffolds provide an initial biochemical substrate for the novel tissue until cells can produce their own extra-cellular matrix. An ideal scaffold for bone tissue engineering must be designed according to the following requirements [3, 10, 11, 15, 16] :  The scaffold material must be non-toxic and allow cell attachment, proliferation, and differentiation;  The scaffold material must degrade into non-toxic products under a controlled degradation rate;  The scaffolds should promote osteointegration, which corresponds to the formation of a chemical bond between bone and the surface of the implanted scaffold without the formation of fibrous tissue. They must also promote osteoconduction and osteogenesis, inducing chemical stimulation of human mesenchymal stem cells into bone-forming osteoblasts;  Scaffolds must be able to deliver growth factors, cytokines, and antibacterial materials. Scaffolds must present sufficient strength and stiffness to withstand stresses in the host tissue environment and adequate surface properties like wettability and surface roughness guaranteeing that a good biomechanical coupling is achieved between the scaffold and the tissue.
Its capacity to stimulate cells is also another important requirement. As electrical signals are critical physiological stimuli that strongly affect cell behavior, electro-active scaffolds could have a great potential as substrates for tissue engineering, enabling cell stimulation, as well as increasing their proliferation and differentiation [17] [18] [19] [20] . In order to produce these scaffolds, different routes are explored, including the use of conductive polymers mixed with non-conductive polymers, and the use of inorganic conductive materials with non-conductive polymers. Pristine graphene (highly pure graphene material) is a two-dimensional carbon nano-filler that can be used to create electro-active scaffolds, with potential to improve mechanical and conductivity properties. Different manufacturing techniques, like solvent precipitation/casting and electrospinning, have been used to produce graphene composites substrates (2D), as well as foams and scaffolds (3D) [21] [22] [23] . However, these techniques are not fully reproducible and do not allow a good control over pore shape, size, and interconnectivity, which are critical parameters to design optimised 3D scaffolds. Additionally, a number of studies reported on the cytotoxicity of graphene-based composite materials and its potential risks [24] [25] [26] , while others reported that graphene-coated surfaces presented good cytocompatibility, stimulating cell proliferation [27, 28] . This paper investigates the potential usage of PCL/ pristine graphene scaffolds, containing very small concentrations of pristine graphene (to avoid potential cytotoxicity effects), for tissue engineering applications. Two major effects were considered; how effective is pristine graphene to improve the mechanical properties even in small concentrations, and the effect of small concentrations of pristine graphene on both cell viability and proliferation. Scaffolds with different material compositions were produced using an extrusion-based additive manufacturing technique, which allows high reproducibility and the fabrication of scaffolds with good control over its topology (pore size, shape, distribution, etc.).
Materials and Methods

Materials
Poly (ε-caprolactone) Poly (ε-caprolactone) (PCL) used in the research was Capa 6500 (Perstorp, UK). PCL is a semi-crystalline biocompatible and biodegradable linear aliphatic polyester with a low melting point and glass transition temperature [29, 30] . Its relevant properties are indicated in Table 1 . Pristine Graphene Pristine graphene was prepared via water-assisted liquid phase exfoliation of graphite. Briefly, 50 mg microcrystalline graphite powder (325 mesh, 99.995% pure, purchased from Alfa Aesar) was immersed in N-methyl-2-pyrrolidone (NMP) mixture with a 0.2 mass fraction of water. The initial concentration of graphite was fixed at 5 mg mL −1 for exfoliation. NMP, 99% extra pure, was purchased from ACROS OR-GANICS. The materials were batch sonicated for 6 hours in a bath sonicator (Elma sonic P60H, Switzerland) at a fixed nominal power and frequency of 100 W and 37 kHz, respectively. Sample dispersions were hanged on for overnight in between sonication and centrifugation, and were centrifuged at 3000 rpm for 30 minutes using a Hettich, EBA20. The upper 75% of the colloidal supernatant were collected and dried in an oven to yield the graphene nano-sheets.
Melt-Blending Process
PCL/pristine graphene blends were prepared according to the following steps: PCL pellets were melted up to 70ºC; Pristine graphene flakes were added to the polymer melt at desired concentrations (0.25% wt, 0.50% wt and 0.75% wt);
The blend was physically mixed for 15 minutes to ensure good pristine graphene dispersion;
After mixing, the blended material was cool down and cut into small pellets.
Scaffold Fabrication
A three-dimensional block model was initially designed in a computer-aided design (CAD) software (SolidWorks, Dassault Systems). A 0 o /90 o lay-down pattern was adopted to obtain pores with a regular square geometry while maintaining a constant filament distance of 680 μm. Scaffolds were produced using the following process parameters: melting temperature (90 o C); slice thickness (220 μm); screw rotation velocity (22 rpm) and deposition velocity (20 mm/s). PCL and PCL/pristine graphene scaffolds containing different concentrations of graphene (0.25% wt, 0.50% wt and 0.75% wt) were produced using a screw-assisted additive manufacturing system from RegenHU (3DD-iscovery, Switzerland). In this process, the material is molten in the liquefier tank, pressed to the barrier screw tank by compressed air, and extruded out through a 330 μm nozzle. PCL/pristine graphene pellets were initially prepared by melt blending. Produced scaffolds presented well dispersed pristine graphene, as previously reported using Raman spectroscopy and micro Raman mapping [4] .
Thermogravimetric Analysis
The onset of thermal degradation and pristine graphene content in the scaffolds was assessed using a TA Instruments Q500 TGA equipped with an evolved gas analysis furnace. Thermogravimetric analysis (TGA) was performed on neat PCL scaffolds as controls, and pristine graphene loaded PCL scaffolds. Scans were performed in an air atmosphere (flow at 60 mL/min) with a temperature range from room temperature to 560°C at a rate of 10°C/min. Measurements were taken using sample mass of 6 ± 1 mg in platinum pans. The weight losses of the PCL/pristine graphene composite structures were monitored and used to calculate the final pristine graphene contents.
Morphological Characterisation
Scanning electron microscopy (SEM) was used to investigate the morphology of produced scaffolds and to measure pore size (PS) and filament width (FW), by comparing obtained values with the initial design parameters (Figure 1) . SEM was conducted with a Quanta 200 SEM system, using an accelerating voltage of 10 kV. All relevant dimensions were measured using the software Image J. The average and standard deviation obtained from 6 measurements are reported for each scaffold.
Apparent Water-in-air Contact Angle
The contact angle indicates the wettability of the material surface, being an important parameter in order to understand the biological interaction between the scaffolds and cells. The balance of forces regarding the surface tension between liquid-vapour ( lv γ ) for a liquid drop and the interfacial tension between the solid Static contact angle measurements were performed using the equipment OCA 15 (Data Physics) and deionised water (4 µL of volume drop, 1 µL/s of velocity). For each condition, five measurements were performed using the sessile drop method. The drop shape was recorded with a high speed framing camera. Measurements were performed after a static time of 20 seconds.
Mechanical Characterisation
Compression tests were performed on both PCL and PCL/pristine graphene scaffolds to assess the effect of the addition of pristine graphene on the mechanical properties of scaffolds. All tests were carried out using scaffolds (5 × 5 × 6 mm) in the dry state at a rate of 1 mm/min, to a strain limit of 0.3 mm/mm (30%), using the INSTRON 4507 system equipped with a 1 kN load cell. During uniaxial compression tests, the software captured force, F, and corresponding displacement values, which were converted into engineering stress (σ) and strain (ε) as follows:
where A is the initial sample cross section area and Δh is the scaffold height variation. The obtained stressstrain data was further processed to determine the compression modulus, E c , according to the procedure previously reported by Fiedler [7] .
Biological Test (In Vitro)
Scaffold Preparation
For biological tests, PCL and PCL/pristine graphene scaffolds were cut into small blocks (11 mm × 11 mm × 6 mm) and placed into 24-well plates for further in vitro measurement. All scaffolds were sterilised by immersion in 70% ethanol for at least 4 hours, then rinsed twice with phosphate buffer solution (PBS) and dried 12 hours in a 37ºC incubator. Prior to cell seeding, scaffolds were dampened using cell culture media (MesenPRO RS™ Basal Medium) for 4 hours to enhance cell attachment and prevent drying.
Cell Seeding
In vitro tests were performed by seeding human adipose-derived stem cells (ADSC) (STEMPRO ® , Invitrogen, USA) on the scaffolds, using passages 3 to 5 suitable for seeding. Cells were cultured in T75 tissue culture flasks (Sigma-Aldrich, UK) with MesenPRO RS™ Basal Medium (Invitrogen, USA) until 80% confluence and harvested by the use of 0.05% trypsin-EDTA solution (Invitrogen, USA), and finally seeded on the scaffolds (100 µL of medium containing around 5×10 4 cells per sample). The cell-seeded scaffolds were incubated at standard conditions (37ºC under 5% CO 2 and 95% humidity) for 2 hours to allow cell attachment, before the addition of 1 mL fresh basal medium [16, 31] .
Cell Viability/Proliferation
Cell viability/proliferation was assessed using the Resazurin assay, commercially known as Alamar Blue assay (Sigma-Aldrich, UK). Resazurin (7-hydroxy-10-oxido-phenoxazin-10-ium-3-one) dye is used to measure cytotoxicity and proliferation [32, 33] . Cells are able to reduce resazurin to resorufin intracellularly by mitochondrial enzyme activity based on their cellular metabolic activity [33, 34] . Briefly, cell viability/proliferation was measured at 3, 7, and 14 days after cell seeding. The medium was changed every 3 days. At each time point, the cell-seeded scaffolds were placed in a new 24 well plate and 1 mL Alamar Blue solution (0.001% in culture medium) was added to each well. The plates were incubated for 4 hours under standard conditions. After incubation, 100 µL of each sample was transferred to a 96-well plate and the fluorescence intensity was measured at 540 nm excitation wavelength and 590 nm emission wavelength with a spectrophotometer (Sunrise; Tecan, Männedorf, Zurich, Switzerland). Experiments were performed at least three times in duplicate.
Cell Morphology
After incubation for 14 days, cell-seeded scaffolds were observed with SEM to assess the cell attachment and morphology. Scaffold samples were fixed with 2% glutaraldehyde solution (Sigma-Aldrich, UK) for 2 hours at room temperature. Then scaffolds were rinsed twice with PBS, dehydrated with graded ethanol series, following 50%, 70%, 80%, 90% and 100%, then 50:50 ethanol:hexamethyldisilazane (v/v) (HMDS) and 100% HMDS (with 10 minutes exposure steps), and then air dried for removal of HMDS [35] . Samples were coated with platinum and imaged using SEM, as described above.
Data Analysis
All data were represented as mean ± standard deviation. Biological results were subjected to one-way analysis of variance (one-way ANOVA) and Tukey's post-hoc test using GraphPad Prism software. Significance levels were set at p < 0.05.
Results and Discussion
Thermogravimetric Analysis
The final content of pristine graphene in the PCL/pristine graphene composite scaffolds was calculated by TGA. The results (Table 2) suggest that the pristine graphene was effectively incorporated into the composite scaffolds, without significant losses during the melt blending process. It is also possible to observe from Table 2 that there is no significant difference on the onset of thermal degradation due to the presence of pristine graphene. Results also indicate that no degradation events occur during the scaffold fabrication process, since the extrusion temperature was 90 o C.
Morphological Analysis
Figures 2 and 3 show the SEM micrographs (top and cross-section) of PCL and PCL/pristine graphene scaffolds. From the top view of these micrographs (Figure 2) , it is possible to observe that scaffolds present a well-defined internal geometry and uniform pore distribution. Cross-section micrographs ( Figure 3) show a good adhesion between adjacent layers. The values of pore size and filament width are summarised in Table 3 . Results show an increase in the filament width due to the increase in pristine graphene, resulting in a slight decrease in both pore size and porosity. Figure 4 shows the corresponding variation trends.
Mechanical Compression Test
The mechanical behaviour of the scaffolds is strongly correlated to the amount of pristine graphene in PCL.
Results show that by increasing the concentration of pristine graphene from 0.13% to 0.78%, the compression modulus increased from 80 MPa to circa 130 MPa (Table 4 and Figure 5 ). This effect is due not only to the reinforcement effect of the pristine graphene but also to the differences in terms of pore size (Table 3) . In comparison to PCL scaffolds, a slight decrease in mechanical properties was observed for scaffolds containing 0.13% pristine graphene, which the authors hypothesise, could be due to the stress concentration in the interface between the polymer and the pristine graphene, which superpose the reinforcement effect of pristine graphene and the reduction on the pore size. Maximum values of compression modulus observed for scaffolds containing higher concentrations of pristine graphene are in the mid range of properties reported for human trabecular bone [36] .
Apparent Water-in-air Contact Angle Analysis
To access the hydrophilicity, the static contact angle was determined and the results presented in Table 5 and Figure 6 . The results show a decrease in the static contact angle by increasing the pristine graphene concentration. It is also possible to observe that pristine graphene, even in very small concentrations, can be used to shift from hydrophobic PCL scaffolds to hydrophilic composite ones. Statically, 0.50% and 0.78% PCL/pristine graphene scaffold exhibited lower contact angle than PCL scaffolds. 
In Vitro Evaluation
The Alamar Blue assay was performed to evaluate cell that at day 3, all scaffolds exhibited similar biological performance. At day 7, 0.78% PCL/pristine graphene scaffolds exhibited greater fluorescence intensity, statistically different form 0%, corresponding to a high cellular activity. This observation can indirectly be correlated to higher cell proliferation rate. On the other hand, based on the statistical analysis, it is possible to notice that on day 14, 0.50% and 0.78% PCL/ pristine graphene scaffolds positively deviated from PCL scaffolds and 0.13% PCL/pristine graphene scaffolds, showing higher cell viability/proliferation rates. It is also possible to observe that through all the time points, the fluorescence activity increased, which indicates an increase in the cell proliferation rate. The negative control (NC) shows no metabolically active cells. According to SEM observations of the cells on the scaffolds (Figure 8 ), extensive cell attachment and cell spreading (pseudopodia) are evident. Cell sheets are seen to bridge orthogonal scaffold filaments, indicating that scaffolds are able to support the growth and proliferation of cells. The isolation and characterisation tests of ADSCs were performed by the supplier (ThermoFisher Scientific, UK). The focus of this paper was to access the effect of low concentration of pristine graphene on both cell viability and proliferation. Differentiations studies, not reported here, are being conducted.
Conclusion
This paper presents the morphological, mechanical, and biological properties of PCL/pristine graphene scaffolds containing different concentrations of pristine graphene. The results indicate that the screw assisted additive manufacturing system considered in this research work is a viable technique to produce these composite scaffolds. The results also show that the addition of pristine graphene has an impact on both the scaffold topology and mechanical properties. For the same process conditions, increasing the content of pristine graphene increases the filament width, decreases pore size, and increases the mechanical performance of the scaffold. 
(A) (B) (C) (D)
It was also observed that pristine graphene slightly reduces the contact angle, thus increasing the cellscaffold affinity and cell viability/proliferation. These results suggest that PCL/pristine graphene scaffolds are promising biomaterial for bone tissue engineering applications.
